Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Examination [Line Items]
Deferred tax assets	$ 789,575,000	$ 831,197,000
Capital loss carryforward	3,265,000	0
Deferred tax assets, valuation allowance	23,776,000	23,080,000
Increase (decrease) in valuation allowance	700,000	9,400,000
Unrecognized tax benefits	6,257,000	241,000	$ 220,000	$ 208,000
Expected decrease to unrecognized tax benefits due to statue expiration	1,900,000
Interest related to uncertain tax benefits	$ 1,000,000
Percentage of tax benefits paid	85.00%
Gain (loss) on tax receivable agreement	$ (4,102,000)	6,101,000	0
Assumed income tax rate	46.70%
Assumed income tax rate when business income deduction is unavailable	54.10%
Tax distribution payable	$ 0
Affiliated Entity | Tax Receivable Agreement, Payments
Income Tax Examination [Line Items]
Related party transaction amounts			0
Tax Distribution | Topco LLC
Income Tax Examination [Line Items]
Tax distributions paid	310,000,000	283,200,000	13,100,000
Topco LLC
Income Tax Examination [Line Items]
Deferred tax assets	765,800,000
Temporary book basis difference	636,500,000
Future tax benefit deductions	148,700,000
Capital loss carryforward	3,300,000
Deferred tax assets, valuation allowance	23,800,000
MLSH1 and MLSH 2 | Affiliated Entity | Tax Receivable Agreement, Payments
Income Tax Examination [Line Items]
Liability payable to related party	718,200,000	748,300,000
Gain (loss) on tax receivable agreement	(4,100,000)
Related party transaction amounts	35,300,000	1,300,000
MLSH1 and MLSH 2 | Affiliated Entity | Interest Payments
Income Tax Examination [Line Items]
Related party transaction amounts	1,100,000
Maravai LifeSciences Holdings, Inc | Tax Distribution | Topco LLC
Income Tax Examination [Line Items]
Tax distributions paid	$ 159,800,000	$ 129,700,000	$ 4,900,000